CD44 and familial pancreatic carcinoma: Considering the small effect of low concentrations of metformin on the proliferation of pancreatic cancer cells in general, it can be inferred that the proliferation of CD133+ cells, but not CD24+, CD44+, ESA+, or CD24+CD44+ESA+ cells, was selectively inhibited.